• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个用于分析米氏动力学系统多重抑制的简单通用方程。

A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems.

作者信息

Chou T C, Talalay P

出版信息

J Biol Chem. 1977 Sep 25;252(18):6438-42.

PMID:893418
Abstract

The summation of the effects of two or more reversible inhibitors of various types on the initial velocity of enzyme systems obeying Michaelis-Menten kinetics is described by the the general relation: (formula: see text) wherein v1,2,3...n is the velocity of reaction in the simultaneous presence of n inhibitors, vi is the velocity observed in the presence of each individual inhibitor, and v0 is the velocity in the absence of inhibition. The derivation is based on the assumption that each enzyme species can combine with no more than one of the inhibitors (i.e. the inhibitors are mutually exclusive). The above relationship holds irrespective of the number of inhibitors, the type of inhibition (competitive, noncompetitive, or uncompetitive), or the kinetic mechanism (sequential or ping-pong) of the enzyme reaction under consideration. Deviations from this equality define synergism or antagonism of inhibitors depending on whether the value of the left side of the above equation is greater or smaller than the right, respectively. Knowledge of the kinetic constants for substrates and inhibitors is not required. If two or more inhibitors act independently (i.e. are not mutually exclusive), their combined effects are necessarily synergistic. Under certain circumstances, described in the text, mutually nonexclusive inhibitors obey the fractional velocity product relationship: v1,2,3...n/v0 = (v1/v0) x (v2/v0) x (v3/v0)...(vn/v0).

摘要

两种或更多种不同类型的可逆抑制剂对遵循米氏动力学的酶系统初速度的影响总和,可用以下一般关系式描述:(公式:见原文)其中v1,2,3...n是n种抑制剂同时存在时的反应速度,vi是每种单独抑制剂存在时观察到的速度,v0是无抑制时的速度。该推导基于每种酶分子与不超过一种抑制剂结合的假设(即抑制剂相互排斥)。上述关系成立,与抑制剂的数量、抑制类型(竞争性、非竞争性或反竞争性)或所考虑的酶反应的动力学机制(顺序或乒乓机制)无关。根据上述等式左侧的值分别大于或小于右侧,与该等式的偏差定义了抑制剂的协同作用或拮抗作用。不需要底物和抑制剂的动力学常数知识。如果两种或更多种抑制剂独立起作用(即不相互排斥),它们的联合效应必然是协同的。在文中所述的某些情况下,相互不排斥的抑制剂遵循分数速度乘积关系:v1,2,3...n/v0 = (v1/v0) × (v2/v0) × (v3/v0)...(vn/v0) 。

相似文献

1
A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems.一个用于分析米氏动力学系统多重抑制的简单通用方程。
J Biol Chem. 1977 Sep 25;252(18):6438-42.
2
The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis.作用于单一酶的完全抑制剂和部分抑制剂之间的相互作用。理论分析。
Mol Pharmacol. 1983 Jul;24(1):30-41.
3
A new plot for multiple enzyme inhibition.一种多重酶抑制的新策略。
Biochem Int. 1983 Aug;7(2):247-53.
4
Kinetic study of an enzyme-catalysed reaction in the presence of novel irreversible-type inhibitors that react with the product of enzymatic catalysis.在存在与酶催化产物发生反应的新型不可逆型抑制剂的情况下,对酶催化反应进行动力学研究。
Bull Math Biol. 1995 Jan;57(1):157-68. doi: 10.1007/BF02458321.
5
Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors.用于分析具有两种或更多种相互排斥和非相互排斥抑制剂的米氏动力学系统及高阶动力学系统抑制作用的通用方程。
Eur J Biochem. 1981 Mar 16;115(1):207-16. doi: 10.1111/j.1432-1033.1981.tb06218.x.
6
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.剂量-效应关系的定量分析:多种药物或酶抑制剂的联合效应
Adv Enzyme Regul. 1984;22:27-55. doi: 10.1016/0065-2571(84)90007-4.
7
Calculation of inhibitor Ki and inhibitor type from the concentration of inhibitor for 50% inhibition for Michaelis-Menten enzymes.根据米氏酶50%抑制率时的抑制剂浓度计算抑制剂的Ki值和抑制剂类型。
Biochem Med Metab Biol. 1987 Jun;37(3):344-9. doi: 10.1016/0885-4505(87)90046-6.
8
Kinetic analysis of enzyme systems with suicide substrate in the presence of a reversible, uncompetitive inhibitor.在可逆性非竞争性抑制剂存在的情况下,使用自杀底物对酶系统进行动力学分析。
Biosystems. 2001 Jun;61(1):5-14. doi: 10.1016/s0303-2647(01)00117-4.
9
THE NATURE AND CONTROL OF REACTIONS IN BIOLUMINESCENCE : WITH SPECIAL REFERENCE TO THE MECHANISM OF REVERSIBLE AND IRREVERSIBLE INHIBITIONS BY HYDROGEN AND HYDROXYL IONS, TEMPERATURE, PRESSURE, ALCOHOL, URETHANE, AND SULFANILAMIDE IN BACTERIA.生物发光中的反应性质和控制:特别参考了氢离子和氢氧根离子、温度、压力、醇类、尿烷和磺胺对细菌中可逆和不可逆抑制作用的机制。
J Gen Physiol. 1945 May 20;28(5):463-537. doi: 10.1085/jgp.28.5.463.
10
Kinetic analysis of enzyme systems with suicide substrate in the presence of a reversible competitive inhibitor, tested by simulated progress curves.在可逆竞争性抑制剂存在的情况下,使用自杀底物对酶系统进行动力学分析,并通过模拟进程曲线进行测试。
Int J Biochem Cell Biol. 2001 Feb;33(2):181-91. doi: 10.1016/s1357-2725(00)00076-5.

引用本文的文献

1
Inhibitory Effects of Aqueous and Hydroalcoholic Extracts from Jatobá Coat ( L.) on Pancreatic Amylase and Starch Absorption.巴西苏木树皮水提取物和水醇提取物对胰淀粉酶及淀粉吸收的抑制作用
Plants (Basel). 2025 Apr 5;14(7):1133. doi: 10.3390/plants14071133.
2
Multi-Layer Autocatalytic Feedback Enables Integral Control Amidst Resource Competition and Across Scales.多层自催化反馈能够在资源竞争和跨尺度过程中实现积分控制。
ACS Synth Biol. 2025 Apr 18;14(4):1041-1061. doi: 10.1021/acssynbio.4c00575. Epub 2025 Mar 21.
3
Synergistic antitumor effect of MK-1775 and CUDC-907 against prostate cancer.
MK-1775与CUDC-907联合对前列腺癌的协同抗肿瘤作用
Invest New Drugs. 2025 Feb;43(1):157-166. doi: 10.1007/s10637-024-01490-8. Epub 2025 Jan 27.
4
Repurposing of sericin combined with dactolisib or vitamin D to combat non-small lung cancer cells through computational and biological investigations.通过计算和生物学研究,将丝胶与达妥昔单抗或维生素 D 联合再利用,以对抗非小细胞肺癌细胞。
Sci Rep. 2024 Nov 7;14(1):27034. doi: 10.1038/s41598-024-76947-0.
5
Analysis of phosphofructokinase-1 activity as affected by pH and ATP concentration.分析 pH 值和 ATP 浓度对磷酸果糖激酶-1 活性的影响。
Sci Rep. 2024 Sep 11;14(1):21192. doi: 10.1038/s41598-024-72028-4.
6
Evaluation of the cytotoxic activity of chemically characterized propolis originating from different geographic regions and vitamin D co-supplementation against human ovarian cancer cells.评价不同地理来源的化学特征明确蜂胶与维生素 D 共同补充对人卵巢癌细胞的细胞毒性作用。
J Ovarian Res. 2024 Sep 7;17(1):181. doi: 10.1186/s13048-024-01500-6.
7
Formulation and Validation of an Extended Sigmoid Emax Model in Pharmacodynamics.药效学中扩展S型Emax模型的构建与验证
Pharm Res. 2024 Sep;41(9):1787-1795. doi: 10.1007/s11095-024-03752-9. Epub 2024 Aug 14.
8
FOXK2 amplification promotes breast cancer development and chemoresistance.FOXK2 扩增促进乳腺癌的发展和化疗耐药性。
Cancer Lett. 2024 Aug 10;597:217074. doi: 10.1016/j.canlet.2024.217074. Epub 2024 Jun 18.
9
Resource allocation in mammalian systems.哺乳动物系统中的资源分配。
Biotechnol Adv. 2024 Mar-Apr;71:108305. doi: 10.1016/j.biotechadv.2023.108305. Epub 2024 Jan 11.
10
YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy.YIV-818-A:一种通过下调雄激素受体、抑制糖皮质激素受体、进行表观遗传调控以及增强阿帕鲁胺、达罗他胺和恩杂鲁胺疗效来治疗前列腺癌的新型治疗药物。
Front Pharmacol. 2023 Oct 4;14:1244655. doi: 10.3389/fphar.2023.1244655. eCollection 2023.